ORTEXORTEX News
Tracking ULS? Get live short interest, options flow, and signals on ORTEX.Sign up free →
UL
Earnings PreviewULS

UL Solutions Surges Into Results While Shorts Hold Ground

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 4 Nov 2026, 04:01

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

UL Solutions jumped 7% on Tuesday and has gained 11.4% over the past week, a move that dwarfs almost everything in its peer group. FCN matched the energy with a 21.9% weekly gain, but EXPO managed just 12.5% and LZ added 1.7%. Most of the remaining peers finished the week flat or lower. That outperformance matters for context: the stock closed at $80.40, up from roughly $74.76 a week ago, yet short interest has barely moved. At 8.8% of the free float, the short position is roughly where it was when a previous preview flagged it as a year high. Shorts did not cover into the rally.

The disconnect between price action and short positioning is the key tension heading into today's print. Short interest edged down just 0.5% on the day and added 0.7% on the week, leaving the absolute level close to its recent peak. Borrow costs remain low at around 0.60%, and availability is generous at 500%, meaning five shares are available to borrow for every one already lent out. There is no squeeze pressure in the lending market. What the data shows is a cohort of short sellers who chose not to reduce exposure despite a 22% gain in the stock over the past month. Options positioning reinforces the caution: the put/call ratio spiked to 0.32 on Monday, 3.7 standard deviations above its 20-day average of 0.22. That is a sharp one-day shift toward defensive positioning, arriving on the session before results.

The analyst community still sees significant upside from current levels. The consensus mean target is $96.62, against a close of $80.40, though that gap has narrowed as the stock recovered from its August lows. After the Q2 report in early August, UL Solutions fell 13% on the day and extended those losses to 15% over the following week. The bull case rests on the company's brand strength in the testing, inspection and certification market and its ability to diversify across service lines. Bears point to regulatory risk, the roughly 24% revenue exposure to China, and the possibility that the company fails to keep pace with technological change in its industry. UBS raised its target to $97 in October while maintaining its Buy rating, a modest move that keeps the firm constructive but signals no particular urgency ahead of the print.

Retail attention is running well above its own recent baseline. The ORTEX alt data layer's Wikipedia-views signal shows a z-score of 3.96 against the company's own trailing 90 days, as of late October. That is an attention reading, not a revenue indicator, but it points to sharply elevated interest from non-institutional observers in the weeks before results.

Insider activity has been uniformly in one direction. CEO Jennifer Scanlon sold shares three times between August and October, all under a pre-arranged 10b5-1 plan, totalling a net reduction of 25,000 shares worth roughly $1.8 million over 90 days. Planned sales carry less informational weight than discretionary ones, but the absence of any buying from management is a data point the market will weigh against the stock's recent recovery.

The print will test whether UL Solutions can demonstrate that the trajectory that alarmed investors in August has genuinely shifted, or whether the rally has simply run ahead of the fundamentals.

Stocks in this article

See the live data behind this article on ORTEX.

Open ULS on ORTEX →

How this article was generated

Generated
4 Nov 2026, 04:15
Data as of
4 Nov 2026, 04:01
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.